Your session is about to expire
← Back to Search
Dexmedetomidine 0.004 MG/ML [Precedex] for Obstetric Anesthesia
Study Summary
This trial is a prospective, randomized, controlled, double-blind, single-center pilot study that will assess the feasibility of a larger study on the use of dexmedetomidine for spinal anesthesia during elective cesarean section.
- Obstetric Anesthesia
- Non-Narcotic Analgesics
- Spinal Anesthesia
- Opioid Analgesics
- Obstetric Analgesia
- Pain relief
- Dexmedetomidine
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are people still being recruited to participate in this research project?
"That is correct, the listing on clinicaltrials.gov does show that this study needs more patients. This trial was posted on March 15th, 2022 and updated October 28th, 2022. The research team is looking for 52 individuals total, at a single location."
Do we have a history of research on the effects of Dexmedetomidine 0.004 MG/ML [Precedex]?
"As of now, there are 118 active clinical trials for Dexmedetomidine 0.004 MG/ML [Precedex] with 25 in Phase 3. Many of these medical studies are based in Karachi, Sindh; however, there are 222 total locations running these kinds of trials."
Is there a high potential for Dexmedetomidine 0.004 MG/ML [Precedex] to cause harm?
"Dexmedetomidine 0.004 MG/ML [Precedex] received a score of 3 because there is efficacy data from Phase 3 trials as well as multiple rounds of safety data."
Why is Dexmedetomidine 0.004 MG/ML [Precedex] given to patients so often?
"Dexmedetomidine 0.004 MG/ML [Precedex] is most commonly used as treatment for disease. It can also be administered to treat multiple other conditions like ventilations, mechanical, cyclic vomiting syndrome, intubations."
How many people are allowed to enroll in this clinical trial?
"That is correct, the online information indicates that this study is still recruiting patients. The trial was first posted on March 15th, 2022 and received its last update on October 28th, 2022. Currently, they are looking for 52 participants from 1 site."
Share this study with friends
Copy Link
Messenger